Genomic characterization of liver metastases from colorectal cancer patients

Oncotarget

Volumn 7, Issue 45, 2016, Pages 72908-72922

  Sayagués, José María ^a   Corchete, Luís Antonio ^b   Gutiérrez, María Laura ^a   Sarasquete, Maria Eugenia ^b   Abad, María del Mar ^c   Bengoechea, Oscar ^c   Fermiñán, Encarna ^a   Anduaga, María Fernanda ^c   del Carmen, Sofia ^c   Iglesias, Manuel ^c   Esteban, Carmen ^c   Angoso, María ^c   Alcazar, Jose Antonio ^c   García, Jacinto ^c   Orfao, Alberto ^a   Muñoz Bellvis, Luís ^c  

^a CSIC   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Colorectal cancer; GEP

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CYCLIN D1; CYCLIN D2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MATRILYSIN; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOL BINDING PROTEIN 4; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR E2F5; BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; TRANSCRIPTOME;

ADH4 GENE; ADULT; AGED; ALB GENE; APOA1 GENE; APOA2 GENE; AQP8 GENE; ARTICLE; BMPR1A GENE; BORA GENE; CA1 GENE; CA2 GENE; CANCER PATIENT; CASP1 GENE; CCND2 GENE; CFHR2 GENE; CFHR3 GENE; CHGA GENE; CKMT1A GENE; CLCA1 GENE; CLCA4 GENE; CLDN1 GENE; CLINICAL ARTICLE; CNBP GENE; CNN1 GENE; COL11A1 GENE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CRP GENE; CTHRC1 GENE; DNAJB4 GENE; DOWN REGULATION; DUSP27 GENE; E2F5 GENE; EGFR GENE; ERBB3 GENE; F2RL1 GENE; FABP4 GENE; FCGBP GENE; FEMALE; FGA GENE; FGB GENE; FGFR2 GENE; FOXQ1 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; GUCA2A GENE; GUCA2B GENE; HDHD2 GENE; HMMR GENE; HP GENE; HPX GENE; HRG GENE; HUMAN; HUMAN TISSUE; IGF1R GENE; IGKC GENE; IGKV1 27 GENE; IGKV1 39 GENE; ITIH1 GENE; KIAA1199 GENE; KIF4A GENE; KRT23 GENE; LIVER METASTASIS; LMOD1 GENE; LRRC1 GENE; MALE; MIER3 GENE; MMP7 GENE; MRPS17 GENE; MS4A12 GENE; MS4A8 GENE; MYH11 GENE; MYLK GENE; NBPF1 GENE; NFE2L3 GENE; ONCOGENE MYC; ORM1 GENE; PCSK5 GENE; PDE9A GENE; PDGFRA GENE; PHF19 GENE; PIK3CA GENE; PLG GENE; PMEPA1 GENE; PML GENE; PRRC2C GENE; PTEN GENE; PTPRH GENE; PTTG1 GENE; QPRT GENE; RASL12 GENE; RBP4 GENE; RBPMS2 GENE; RHOA GENE; RNF152 GENE; RNF43 GENE; RRP1 GENE; SAA2 SAA4 GENE; SIGNAL TRANSDUCTION; SKA1 GENE; SLC23A3 GENE; SLC26A3 GENE; SLC4A4 GENE; SMAD2 GENE; SMAD4 GENE; SMAD5 GENE; SMAD6 GENE; SMAD7 GENE; SOCS2 GENE; SPC24 GENE; SPINK4 GENE; SRPX2 GENE; TACSTD2 GENE; TFCP2L1 GENE; TUMOR MICROENVIRONMENT; UGT2B17 GENE; UGT2B4 GENE; UPREGULATION; UQCRC2 GENE; ZG16 GENE; BIOLOGY; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; RNA INTERFERENCE; SECONDARY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84995743752     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12140     Document Type: Article

References (61)

1. Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, Chu KS, Chan HM, Wang JY. The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg. 2007; 11:660-5.
2. Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer. 2008; 8:187.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectaltumor development. N Engl J Med. 1988; 319:525-32.
4. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science. 1987; 238:193-7.
5. Negri FV, Bozzetti C, Lagrasta CA, Crafa P, Bonasoni MP, Camisa R, Pedrazzi G, Ardizzoni A. PTEN status in advanced colorectal cancer treated with cetuximab. Br J Cancer. 2010; 102:162-4.
6. Lan YT, Jen-Kou L, Lin CH, Yang SH, Lin CC, Wang HS, Chen WS, Lin TC, Jiang JK, Chang SC. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers. J Surg Oncol. 2015; 111:905-10.
7. Xu X, Chen R, Li Z, Huang N, Wu X, Li S, Li Y, Wu S. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFbetaR1. BMC Cancer. 2015; 15:1023.
8. Mollevi DG, Serrano T, Ginesta MM, Valls J, Torras J, Navarro M, Ramos E, Germà JR, Jaurrieta E, Moreno V, Figueras J, Capellà G, Villanueva A. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 2007; 28:1241-6.
9. Mlcochova J, Faltejskova-Vychytilova P, Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss I, Vyzula R, Negrini M, Slaby O1. MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. Oncotarget. 2015; 6:38695-704. doi: 10.18632/oncotarget.5735.
10. Chang SW, Yue J, Wang BC, Zhang XL. miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3. Int J Clin Exp Pathol. 2015; 8:12853-60.
11. Zheng K, Liu W, Liu Y, Jiang C, Qian Q. MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1. Oncol Lett. 2015; 9:869-74.
12. Gutierrez ML, Corchete L, Teodosio C, Sarasquete ME, del Mar AM, Iglesias M, Esteban C, Sayagues JM, Orfao A, Muñoz-Bellvis L. Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas. Oncotarget. 2015; 6:19070-86.
13. Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors. Oncologist. 2015; 20:127-33.
14. Kelley RK, Van Bebber SL, Phillips KA, Venook AP. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011; 9:13-25.
15. Mudduluru G, Abba M, Batliner J, Patil N, Scharp M, Lunavat TR, Leupold JH, Oleksiuk O, Juraeva D, Thiele W, Rothley M, Benner A, Ben-Neriah Y, et al. A Systematic Approach to Defining the microRNA Landscape in Metastasis. Cancer Res. 2015; 75:3010-9.
16. Munoz-Bellvis L, Fontanillo C, Gonzalez-Gonzalez M, Garcia E, Iglesias M, Esteban C, Gutierrez ML, Abad MM, Bengoechea O, De Las Rivas J, Orfao A, Sayagués JM. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays. Mod Pathol. 2012; 25:590-601.
17. Furi I, Kalmar A, Wichmann B, Spisak S, Scholler A, Bartak B, Tulassay Z, Molnár B. Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line. PLoS ONE. 2015; 10:e0131699.
18. Peng X, Luo Z, Kang Q, Deng D, Wang Q, Peng H, Wang S, Wei Z. FOXQ1 mediates the crosstalk between TGF-beta and Wnt signaling pathways in the progression of colorectal cancer. Cancer Biol Ther. 2015; 16:1099-109.
19. Kinugasa T, Akagi Y, Ochi T, Tanaka N, Kawahara A, Ishibashi Y, Gotanda Y, Yamaguchi K, Shiratuchi I, Oka Y, Kage M, Shirouzu K. Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. Anticancer Res. 2012; 32:2309-14.
20. Yang B, Cao L, Liu B, McCaig CD, Pu J. The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1. PLoS ONE. 2013; 8:e60861.
21. Zhu J, Li C, Ji W. Identification of genes in ulcerative colitis associated colorectal cancer based on centrality analysis of co-expression network. Neoplasma. 2015; 62:756-64.
22. Peng Y, Li X, Wu M, Yang J, Liu M, Zhang W, Xiang B, Wang X, Li X, Li G, Shen S. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. Mol Biosyst. 2012; 8:3077-88.
23. Wang L, Hahnloser D, Boardman LA, Burgart LJ, French AJ, Thibodeau S. Loss of expression of zymogen granule protein 16 in colorectal cancer. Cancer Res Abstract. 2005; 1:452.
24. Yasui Y, Tanaka T. Protein expression analysis of inflammation-related colon carcinogenesis. J Carcinog. 2009; 8:10.
25. Pandurangan AK. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev. 2013; 14:2201-5.
26. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995; 95:55-65.
27. Marszalowicz GP, Snook AE, Magee MS, Merlino D, Berman-Booty LD, Waldman SA. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer. Oncotarget. 2014; 5:9460-71. doi: 10.18632/oncotarget.2455.
28. Szmida E, Karpinski P, Leszczynski P, Sedziak T, Kielan W, Ostasiewicz P, Sasiadek MM. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer. J Appl Genet. 2015; 56:185-92.
29. Caro XJ. New concepts in primary fibrositis syndrome. Compr Ther. 1989; 15:14-22.
30. Zhang GJ, Zhou H, Xiao HX, Li Y, Zhou T. MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer. 2014; 14:109.
31. Brunschwig EB, Wilson K, Mack D, Dawson D, Lawrence E, Willson JK, Lu S, Nosrati A, Rerko RM, Swinler S, Beard L, Lutterbaugh JD, et al. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res. 2003; 63:1568-75.
32. Fournier PG, Juarez P, Jiang G, Clines GA, Niewolna M, Kim HS, Walton HW, Peng XH, Liu Y, Mohammad KS, Wells CD, Chirgwin JM, Guise TA. The TGF-beta Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. Cancer Cell. 2015; 27:809-21.
33. Butz H, Racz K, Hunyady L, Patocs A. Crosstalk between TGF-beta signaling and the microRNA machinery. Trends Pharmacol Sci. 2012; 33:382-93.
34. Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS ONE. 2011; 6:e16636.
35. Iino I, Kikuchi H, Miyazaki S, Hiramatsu Y, Ohta M, Kamiya K, Kusama Y, Baba S, Setou M, Konno H. Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis. Cancer Sci. 2013; 104:624-30.
36. Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, et al. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics. 2013; 14:589.
37. Basu S, Bhattacharyya SN. Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells. Nucleic Acids Res. 2014; 42:7170-85.
38. Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J Natl Cancer Inst. 2015; 107.
39. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449:682-8.
40. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem. 2010; 285:7986-94.
41. Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery. 2011; 150:916-22.
42. Liu Y, Zhou J, Zhang C, Fu W, Xiao X, Ruan S, Zhang Y, Luo X, Tang M. HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival. Int J Clin Exp Pathol. 2014; 7:969-77.
43. Zhang GJ, Li Y, Zhou H, Xiao HX, Zhou T. miR20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis. Mol Med Rep. 2014; 10:283-91.
44. Chai H, Liu M, Tian R, Li X, Tang H. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines. Acta Biochim Biophys Sin (Shanghai). 2011; 43:217-25.
45. Choi S, Korstanje R. Proprotein convertases in high-density lipoprotein metabolism. Biomark Res. 2013; 1:27.
46. Wang JL, Lin YW, Chen HM, Kong X, Xiong H, Shen N, Hong J, Fang JY. Calcium prevents tumorigenesis in a mouse model of colorectal cancer. PLoS ONE. 2011; 6:e22566.
47. Letellier E, Schmitz M, Baig K, Beaume N, Schwartz C, Frasquilho S, Antunes L, Marcon N, Nazarov PV, Vallar L, Even J, Haan S. Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. Br J Cancer. 2014; 111:726-35.
48. Jiang Y, Meng Q, Qi J, Shen H, Sun S. MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition. Tumour Biol. 2015; 36:7641-7.
49. Qian XL, Li YQ, Gu F, Liu FF, Li WD, Zhang XM, Fu L. Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients. Biochem Biophys Res Commun. 2012; 427:60-6.
50. Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, Uetake H, Tanaka H, Sugihara K. Clinical significance of osteoprotegerin expression in human colorectal cancer. Clin Cancer Res. 2011; 17:2444-50.
51. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Björling L, Ponten F. Towards a knowledgebased Human Protein Atlas. Nat Biotechnol. 2010; 28:1248-50.
52. Nanjappa V, Thomas JK, Marimuthu A, Muthusamy B, Radhakrishnan A, Sharma R, Ahmad Khan A, Balakrishnan L, Sahasrabuddhe NA, Kumar S, Jhaveri BN, Sheth KV, Kumar Khatana R, et al. Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res. 2014; 42:D959-D965.
53. World Health Organization. WHO International Histological Classification of Tumors, Vol 1-25. Geneva, 1967-1981; 2nd edn, Berlin: Springer-Verlag, 1988-1992.
54. Greene FL. Current TNM staging of colorectal cancer. Lancet Oncol. 2007; 8:572-3.
55. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003; 34:374-8.
56. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001; 98:5116-21.
57. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011; 44:839-47.
58. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009; 37(Database issue):D105-D110.
59. Risueno A, Fontanillo C, Dinger ME, De las RJ. GATExplorer: genomic and transcriptomic explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs. BMC Bioinformatics. 2010; 11:221.
60. Gabriel KR, Odoroff CL. Biplots in biomedical research. Stat Med. 1990; 9:469-85.
61. Kim SK, Kim SY, Kim JH, Roh SA, Cho DH, Kim YS, Kim JC. A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients. Mol Oncol. 2014; 8:1653-66.